Application of bridging study design in preventive vaccine clinical trials.
10.3760/cma.j.cn112150-20230224-00156
- VernacularTitle:桥接试验设计在预防性疫苗临床研究中的应用
- Author:
Ya Wen ZHU
1
;
Xin XIA
1
;
Zhuo Pei LI
1
;
Yan Fei WU
2
;
Feng Cai ZHU
3
;
Jing Xin LI
1
Author Information
1. School of Public Health, Nanjing Medical University, Nanjing 211166, China.
2. School of Public Health, Southeast University, Nanjing 210009, China.
3. National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Research Design;
Biomedical Research;
Immunization;
Vaccines/therapeutic use*
- From:
Chinese Journal of Preventive Medicine
2023;57(12):2201-2211
- CountryChina
- Language:Chinese
-
Abstract:
Bridging study in vaccine clinical trials means a series of small-scale additional tests on the basis that the original safety and effectiveness of a vaccine have been confirmed in clinical trials, to prove that the characteristics of safety, immunogenicity and effectiveness of a vaccine are similar or consistent after component, population and immunization procedure change to other types which can extrapolate data from existing clinical trials. Compared with traditional vaccine clinical trials, bridging trials can promote the approval of vaccines to the market, accelerate the expansion of vaccine application, and promote the use of vaccines across regions and populations. In recent years, the application of bridge study design in vaccine clinical research has become more and more common. In order to better guide and promote the application of bridging trial design in the field of vaccine clinical research, we reviewed the design characteristics and application examples of bridging study design in vaccine clinical trials, and systematically elaborated the design ideas, key points and statistical evaluation methods of bridging study.
